CDEK
← All organizations

SmithKline Beckman

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

First marketed drug

Jan 31, 1984

Last known activity

Oct 20, 1988

Acquired by SmithKline Beecham → GlaxoSmithKline on Jan 1, 1989

Timeline

1980s

  1. Jul 1, 1980

    Allergan (1948)— Acquired

  2. Jan 1, 1982

    SmithKline Beckman— Founded

  3. Jan 1, 1982

    Smith, Kline & French— Acquired

  4. Jan 31, 1984

    estradiol— Marketing Organization

  5. Jan 1, 1988

    International Clinical Laboratories— Acquired

  6. Jun 10, 1988

    prednisone— NDA Secondary Org

  7. Jan 1, 1989

    SmithKline Beecham— Acquired By

2000s

  1. Jan 1, 2000

    GlaxoSmithKline— Now

Drugs by trial phase (148 distinct, 608 trials)

Other trials (0 own, 4 via acquisition)

Indications

Approved for

Marketed drugs (12)

Subsidiaries (3 direct, 13 total across the full acquisition tree)

Details

Founded
Philadelphia, PA, US Jan 1, 1982
Last known activity
Oct 20, 1988